NYSE: TRAKRepositrak Inc Stock
$15.21-0.41 (-2.62%)
Updated Apr 16, 2024
TRAK Price
$15.21
Fair Value Price
N/A
Market Cap
$276.97M
52 Week Low
$6.25
52 Week High
$17.93
P/E
52.45x
P/B
6.05x
P/S
9.18x
PEG
8.15x
Dividend Yield
0.41%
Revenue
$19.81M
Earnings
$5.87M
Gross Margin
83.1%
Operating Margin
31.88%
Profit Margin
26.7%
Debt to Equity
0.1
Operating Cash Flow
$8M
Beta
0.75
Next Earnings
May 13, 2024
Ex-Dividend
Mar 27, 2024
Next Dividend
May 10, 2024
TRAK Overview
Park City Group, Inc., a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers. It also provides ScoreTracker, Vendor Managed Inventory, Store Level Ordering and Replenishment, Enterprise Supply Chain Planning, Fresh Market Manager, and ActionManager supply chain solutions to manage inventory, product mix, and labor. In addition, the company offers business-consulting services to suppliers and retailers in the grocery, convenience store, and specialty retail industries, as well as professional consulting services. It primarily serves multi-store retail chains, wholesalers and distributors, and their suppliers. The company is headquartered in Murray, Utah.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TRAK scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TRAK ($15.21) is trading above its intrinsic value of $2.24, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TRAK is poor value based on its earnings relative to its share price (52.45x), compared to the US market average (41.98x)
P/E vs Market Valuation
TRAK is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more TRAK due diligence checks available for Premium users.
Be the first to know about important TRAK news, forecast changes, insider trades & much more!
TRAK News
Valuation
TRAK price to earnings (PE)
For valuing profitable companies with steady earnings
Company
52.45x
Industry
99.33x
Market
41.98x
TRAK is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
TRAK is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
TRAK price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
6.05x
Industry
6.48x
TRAK is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
TRAK price to earnings growth (PEG)
For valuing profitable companies with growth potential
TRAK is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
TRAK's financial health
Profit margin
Revenue
$5.1M
Net Income
$1.5M
Profit Margin
25.5%
TRAK's Earnings (EBIT) of $6.32M... subscribe to Premium to read more.
Interest Coverage Financials
TRAK's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$50.3M
Liabilities
$4.6M
Debt to equity
0.1
TRAK's short-term assets ($27.57M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TRAK's short-term assets ($27.57M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TRAK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
TRAK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$931.2k
Investing
-$16.4k
Financing
-$1.4M
TRAK's operating cash flow ($8.01M)... subscribe to Premium to read more.
Debt Coverage Financials
TRAK vs App Stocks
Repositrak Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.